Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017-2020.
Karlowsky JA, Lob SH, Khan TK, Chen WT, Woo PCY, Seto WH, Ip M, Leung SWM, Wong QW, Chau RWY, DeRyke CA, Young K, Motyl MR, Sahm DF. Karlowsky JA, et al. Among authors: sahm df. J Glob Antimicrob Resist. 2023 Jun;33:260-266. doi: 10.1016/j.jgar.2023.04.004. Epub 2023 Apr 21. J Glob Antimicrob Resist. 2023. PMID: 37086892 Free article.
Erratum for Karlowsky et al., "In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019".
Karlowsky JA, Hackel MA, Takemura M, Yamano Y, Echols R, Sahm DF. Karlowsky JA, et al. Among authors: sahm df. Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0042723. doi: 10.1128/aac.00427-23. Epub 2023 May 8. Antimicrob Agents Chemother. 2023. PMID: 37154749 Free PMC article. No abstract available.
Susceptibility profile and β-lactamase content of global Pseudomonas aeruginosa isolates resistant to ceftolozane/tazobactam and/or imipenem/relebactam-SMART 2016-21.
Karlowsky JA, Lob SH, Estabrook MA, Siddiqui F, DeRyke CA, Young K, Motyl MR, Sahm DF. Karlowsky JA, et al. Among authors: sahm df. JAC Antimicrob Resist. 2023 Jun 28;5(3):dlad080. doi: 10.1093/jacamr/dlad080. eCollection 2023 Jun. JAC Antimicrob Resist. 2023. PMID: 37388237 Free PMC article.
Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan-SMART 2012-2021.
Karlowsky JA, Wise MG, Hsieh TC, Lu HC, Chen WT, Cheng MH, Siddiqui F, Young K, Motyl MR, Sahm DF. Karlowsky JA, et al. Among authors: sahm df. J Glob Antimicrob Resist. 2023 Sep;34:106-112. doi: 10.1016/j.jgar.2023.06.013. Epub 2023 Jul 5. J Glob Antimicrob Resist. 2023. PMID: 37419182 Free article.
In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021.
Wise MG, Karlowsky JA, Mohamed N, Kamat S, Sahm DF. Wise MG, et al. Among authors: sahm df. Eur J Clin Microbiol Infect Dis. 2023 Sep;42(9):1135-1143. doi: 10.1007/s10096-023-04645-2. Epub 2023 Aug 1. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37526796 Free PMC article.
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)-SMART 2017-21.
Karlowsky JA, Lob SH, Hawser SP, Kothari N, Siddiqui F, Alekseeva I, DeRyke CA, Young K, Motyl MR, Sahm DF. Karlowsky JA, et al. Among authors: sahm df. JAC Antimicrob Resist. 2023 Aug 11;5(4):dlad098. doi: 10.1093/jacamr/dlad098. eCollection 2023 Aug. JAC Antimicrob Resist. 2023. PMID: 37577157 Free PMC article.
296 results